Fractional CO2 Laser Therapy for Survivors of Breast Malignancies

Inclusion Criteria: * Women with non-metastatic breast cancer with any hormone receptor and Her 2 neu status who have completed surgery, chemotherapy, and radiation and are currently on endocrine therapy, single agent Herceptin, or observation * Symptoms of urogenital atrophy including dyspareunia or vaginal dryness Exclusion Criteria: * Patients with metastatic breast cancer * Vaginal stenosis which would not allow vaginal probe to be placed (based on physician exam) * Active genital infection at the time of enrollment (if present initially, can be treated and then patient can be re-evaluated for eligibility) * Pelvic organ prolapse greater than stage II * Prior reconstructive pelvic surgery involving mesh * Hormone replacement therapy, vaginal estrogen therapy, DHEA, or biosynthetics within 6 weeks prior to enrollment